Seven studies reported no significantly differences in AMH and AFC levels in patients with breast cancer (Lutchman Singh et al., 2007; Yu et al., 2010; Naasan et al., 2016; Pereira et al., 2016; Quinn et al., 2017; Goldrat et al., 2019; Gunnala et al., 2019). Here, AMH is linked to breast carcinoma.